Different studies showed that when patients are better informed about the benefits and harms of interventions (eg, surgeries, screening tests, medications), they tend to decline low-value care. These findings might explain why SDM has been promoted to reduce low-value care. Focusing on the conversations between [...]
Consistent evidence shows pathology services are overused worldwide and that about one-third of testing is unnecessary. Audit and feedback (AF) is effective for improving care but few trials evaluating AF to reduce pathology test requesting in primary care have been conducted. The aim of this [...]
Limited evidence is available on the cost-effectiveness of diagnostic imaging for back, neck, knee, and shoulder complaints. Decision analytic modelling may be an appropriate method to synthesise evidence from multiple sources, and overcomes issues with trial-based economic evaluations.
Since 2020, hundreds of thousands of more deaths than expected have been observed across the globe. Amid the coronavirus 2019 (COVID-19) pandemic, current research priorities are to control the spread of infection and minimise loss of life. However, there may be future opportunities to learn [...]
Many administrative health data-based studies define patient cohorts using procedure and diagnosis codes. The impact these criteria have on a study’s final cohort is not always transparent to co-investigators or other audiences if access to the research data is restricted. We developed a SAS and [...]
Growing evidence suggests overuse of medications is widespread within low- and middle-income countries, across multiple drug classes, with few data of solutions from randomized trials. Opportunities exist to build collaborations to rigorously develop and evaluate potential solutions to reduce overuse of medications.
Quality use of anti-hypertensive and cholesterol-lowering medications is crucial for successful cardiovascular disease management. This systematic review aimed to estimate levels of over and underuse of services for primary and secondary prevention of cardiovascular diseases from 2000 to 2020
Pharmaceutical waste is an important and growing environmental concern. Many drugs have been detected in significant concentrations in waterways, and they are likely to be particularly harmful when "constantly introduced to aquatic ecosystems," such as drugs inappropriately discarded on a daily basis. Environmental contamination with [...]
Verkerk and colleagues explored the key drivers of low-value care from the perspective of 18 policy-makers and researchers who had led and evaluated at least one initiative to reduce low-value care or had been responsible for reducing low-value care in an organisation. They identified several [...]
Low-value services have limited or no benefit to patients. Rates of low-value service in public hospitals may vary by patient insurance status, given that there may be different financial incentives for treatment of privately insured patients.